Literature DB >> 21346347

Clinical and radiological outcomes after intracranial atherosclerotic stroke: a comprehensive approach comparing stroke subtypes.

Suk Jae Kim1, Sookyoung Ryoo, Gyeong-Moon Kim, Chin-Sang Chung, Kwang Ho Lee, Oh Young Bang.   

Abstract

BACKGROUND: We previously reported that intracranial large-artery atherosclerotic stroke (ICAS) had a relatively large salvageable area of less severe hypoperfusion. However, information regarding the outcome after ICAS is lacking. We hypothesized ICAS would show more favorable clinical and radiological outcomes than other stroke mechanisms.
METHODS: Consecutive patients underwent admission (n = 149) and follow-up (n = 80) multiparametric magnetic resonance imaging (MRI) for acute middle cerebral artery infarcts within 6 h of symptom onset. T(max) perfusion lesion maps were generated. We assessed the difference in the degree of infarct growth ([follow-up diffusion-weighted imaging (DWI) volume--initial DWI volume]/initial penumbra volume) and the presence of excellent long-term outcome [defined as a modified Rankin scale (mRS) score ≤ 2 and a modified Barthel index (mBI) ≥ 90 at 3 months].
RESULTS: Of 149 patients, 24 (16.1%) had ICAS, 75 (50.3%) had cardioembolic stroke, 21 (14.1%) had extracranial large-artery atherosclerotic stroke, and 29 (19.5%) had cryptogenic embolic stroke. Despite a higher recurrence rate in patients with ICAS compared to other subtypes (p = 0.026), the long-term outcome was better in ICAS (p = 0.003 for an mRS score ≤ 2 and p = 0.004 for an mBI ≥ 90). Among 80 patients who underwent follow-up MRI, patients who had minimal infarct growth (less than 10%) were more prevalent among the patients with ICAS (p = 0.004). Multivariate testing revealed that ICAS was independently associated with both excellent long-term outcome (OR = 3.45; 95% CI = 1.11-10.78) and minimal infarct growth (OR = 10.40; 95% CI = 1.20-90.11).
CONCLUSION: Our data show that patients with ICAS have favorable clinical and radiological outcomes compared with other subtypes.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21346347     DOI: 10.1159/000323610

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  5 in total

1.  Left ventricular hypertrabeculation/noncompaction as a cause of juvenile embolic stroke.

Authors:  J Finsterer; C Stöllberger
Journal:  Herz       Date:  2013-12-21       Impact factor: 1.443

2.  Predictors of symptomatic intracranial hemorrhage after endovascular treatment for acute large vessel occlusion: data from ANGEL-ACT registry.

Authors:  Dapeng Sun; Xiaochuan Huo; Baixue Jia; Xu Tong; Gaoting Ma; Anxin Wang; Ning Ma; Feng Gao; Dapeng Mo; Zhongrong Miao
Journal:  J Thromb Thrombolysis       Date:  2022-08-01       Impact factor: 5.221

3.  Worse stroke outcome in atrial fibrillation is explained by more severe hypoperfusion, infarct growth, and hemorrhagic transformation.

Authors:  Hans T H Tu; Bruce C V Campbell; Soren Christensen; Patricia M Desmond; Deidre A De Silva; Mark W Parsons; Leonid Churilov; Maarten G Lansberg; Michael Mlynash; Jean-Marc Olivot; Matus Straka; Roland Bammer; Gregory W Albers; Geoffrey A Donnan; Stephen M Davis
Journal:  Int J Stroke       Date:  2013-03-12       Impact factor: 5.266

Review 4.  Current Opinion on Endovascular Therapy for Emergent Large Vessel Occlusion Due to Underlying Intracranial Atherosclerotic Stenosis.

Authors:  Dong Hun Kang; Woong Yoon
Journal:  Korean J Radiol       Date:  2019-05       Impact factor: 3.500

5.  Understanding of Pathophysiology and Optimal Treatment for Anterior Circulation Large Vessel Occlusion beyond 24 h from Onset of Stroke.

Authors:  Takashi Mizowaki; Atsushi Uyama; Atsushi Fujita; Jun Imura; Hiroyasu Shose; Hirotomo Tanaka; Yoshiyuki Takaishi; Takeshi Kondoh
Journal:  Asian J Neurosurg       Date:  2021-09-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.